Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr-Jun;62(2):457-463.
doi: 10.47162/RJME.62.2.11.

Neuroendocrine tumors (NETs) - experience of a single Center

Affiliations

Neuroendocrine tumors (NETs) - experience of a single Center

Mihaela Cornelia Şincu et al. Rom J Morphol Embryol. 2021 Apr-Jun.

Abstract

Introduction: Neuroendocrine neoplasms (NENs) are a heterogeneous group of tumors arising from cells that are part of the diffuse neuroendocrine system.

Patients, materials and methods: We conducted a retrospective study in which we included a number of 91 cases diagnosed with neuroendocrine tumors (NETs). Descriptive statistics was performed: number of cases based on location, distribution by gender (male∕female), distribution by age, and we also performed a morphological and immunohistochemical (IHC) study.

Results: The highest number of cases was found in lungs (60 cases). Tumors located on the skin, breast or bladder have been discovered, locations considered rare for this type of tumor. Of all cases diagnosed in the lungs, 59 were diagnosed as small cell carcinomas (SCCs) and only one case as NET. All surgical specimens were positive for chromogranin A (CgA), with a different expression for the other immunomarkers. For the lung biopsies, the most frequently IHC staining was CgA and cluster of differentiation 56 (CD56), with an increased positivity for the latter.

Conclusions: CgA remains the most sensitive immunomarker in the diagnosis of NETs. CD56 is the most widely used immunomarker for diagnosing small cell lung tumors. Positive expression of thyroid transcription factor 1 (TTF1) immunomarker does not confirm pulmonary origin of SCCs.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interests.

Figures

Figure 1
Figure 1
Tumors distribution: primary site
Figure 2
Figure 2
(A and B) Merkel cell carcinoma. HE staining: (A) ×50; (B) ×200. HE: Hematoxylin–Eosin
Figure 3
Figure 3
Merkel cell carcinoma: immunoexpressions (×200) of CgA (A), CD56 (B), synaptophysin (C), and CK20 (D). CD56: Cluster of differentiation 56; CgA: Chromogranin A; CK20: Cytokeratin 20
Figure 4
Figure 4
(A–D) Small cell carcinoma of the bladder; immunoexpressions (×200) of CD56 (C) and NSE (D). HE staining: (A) ×50; (B) ×200. CD56: Cluster of differentiation 56; HE: Hematoxylin–Eosin; NSE: Neuron-specific enolase

References

    1. Cives M, Strosberg JR. Gastroenteropancreatic neuroendocrine tumors. CA Cancer J Clin. 2018;68(6):471–487. - PubMed
    1. Oronsky B, Ma PC, Morgensztern D, Carter CA. Nothing but NET: a review of neuroendocrine tumors and carcinomas. Neoplasia. 2017;19(12):991–1002. - PMC - PubMed
    1. Kaltsas GA, Besser GM, Grossman AB. The diagnosis and medical management of advanced neuroendocrine tumors. Endocr Rev. 2004;25(3):458–511. - PubMed
    1. Zheng Z, Chen C, Jiang L, Zhou X, Dai X, Song Y, Li Y. Incidence and risk factors of gastrointestinal neuroendocrine neoplasm metastasis in liver, lung, bone, and brain: a population-based study. Cancer Med. 2019;8(17):7288–7298. - PMC - PubMed
    1. Modlin IM, Shapiro MD, Kidd M. Siegfried Oberndorfer: origins and perspectives of carcinoid tumors. Hum Pathol. 2004;35(12):1440–1451. - PubMed